top of page
Browse by category
Search
Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression
Tetra Pharm Technologies has reached a significant in developing its compound for appetite suppression, TPT0701, following the successful...
Skye to develop nimacimab for the treatment of obesity by targeting the endocannabinoid system
Skye Bioscience, a pharmaceutical company developing drugs targeting the endocannabinoid system (ECS), has announced that it plans to...
Browse by tag
bottom of page